Camelia Spiridon

Medicine · Health Sciences

6h-index320citations8works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Transplantation Outcomes and Treatments(3), Monoclonal and Polyclonal Antibodies Research(3), Transplantation: Methods and Outcomes(3), Glycosylation and Glycoproteins Research(2), HER2/EGFR in Cancer Research(2)

Publications8 total

CD30, a marker to detect the high‐risk kidney transplant recipients
Clinical Transplantation·2008· 29 cited
Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation
Clinical Transplantation·2007· 21 cited
Evaluation of Soluble CD30 as an Immunologic Marker in Heart Transplant Recipients
Transplantation Proceedings·2006· 15 cited
23-P
Human Immunology·2006
Evaluation of HLA antibodies and sCD30 in heart transplantation
Human Immunology·2005
The Generation and Anti-Myeloma Activity of a Chimeric Anti-CD54 Antibody, cUV3
Journal of Immunotherapy·2004· 11 cited
A Comparison of the<b><i>in Vitro</i></b>and<b><i>in Vivo</i></b>Activities of IgG and F(ab′)2 Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies
Clinical Cancer Research·2004· 86 cited
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
PubMed·2002· 158 cited

Frequent Co-authors

Afzal Nikaein(5), Judson Hunt(5), Michael J. Mack(5), Ellen S. Vitetta(3), Jed Rosenthal(3), E. Eichhorn(3), Mitchell J. Magee(3), Todd Dewey(3), Mark Lerman(2), Richard Dickerman(2), Alyce Anderson(2), Mary Currier(2), Maria Ana Ghetie(1), Jonathan W. Uhr(1), Radu Marcheş(1), Jia Ling Li(1), Guo Liang Shen(1), Sarah E. Guinn(1), Allan L. Anderson(1), Joan E. Smallshaw(1)